Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Invested Capital (2019 - 2025)

Historic Invested Capital for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $1.1 billion.

  • IDEAYA Biosciences' Invested Capital fell 748.75% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 748.75%. This contributed to the annual value of $1.1 billion for FY2024, which is 7053.04% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Invested Capital stood at $1.1 billion for Q3 2025, which was down 748.75% from $959.7 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Invested Capital registered a high of $1.2 billion during Q3 2024, and its lowest value of $233.1 million during Q1 2021.
  • For the 5-year period, IDEAYA Biosciences' Invested Capital averaged around $606.1 million, with its median value being $501.6 million (2023).
  • As far as peak fluctuations go, IDEAYA Biosciences' Invested Capital surged by 18019.26% in 2024, and later tumbled by 748.75% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Invested Capital (Quarter) stood at $301.5 million in 2021, then grew by 15.9% to $349.5 million in 2022, then skyrocketed by 77.73% to $621.1 million in 2023, then surged by 70.53% to $1.1 billion in 2024, then rose by 3.11% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $959.7 million for Q2 2025, and $1.0 billion during Q1 2025.